Taylor Andrew Lawrence
Company insiders · Chief Financial Officer · Orchestra BioMed Holdings, Inc.
- Reported transaction lines
- 2
- Buy lines
- 1
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-112
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Taylor Andrew Lawrence Chief Financial Officer · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | Other transactionFiling detailsSEC transaction code F Common Stock, par value $0.0001 per share · Direct ownership · Reported balance after transaction: 587913 · Securities delivered or withheld for tax or exercise payment · Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations. | 2026-11-20 | 2026-11-20 | 3,076 shares/units | SEC 4 |
| Taylor Andrew Lawrence Chief Financial Officer · Orchestra BioMed Holdings, Inc. | OBIO Orchestra BioMed Holdings, Inc. | BuyFiling detailsSEC transaction code P Common Stock, par value $0.0001 per share · Direct ownership · Reported balance after transaction: 590989 · SEC code covers open-market or private transactions · These shares were purchased in an underwritten public offering of the Issuer at the public offering price of $5.00 per share. | 2026-11-09 | 2026-11-09 | ≈ $5,000.00 1,000 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.